$22.51
1.67%
NYSE, Oct 05, 04:07 pm EDT. Closed.
ISIN
US28414H1032
Symbol
ELAN

Elanco Animal Health, Inc. Target price 2026 - Analyst rating & recommendation

Elanco Animal Health, Inc. Classifications & Recommendation

Buy
91%
Hold
9%

Elanco Animal Health, Inc. Price Target

Target Price $31.62
Price $22.51
Potential
Number of Estimates 16
16 Analysts have issued a price target Elanco Animal Health, Inc. 2027 . The average Elanco Animal Health, Inc. target price is $31.62. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 23 analysts: 21 Analysts recommend Elanco Animal Health, Inc. to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Elanco Animal Health, Inc. stock has an average upside potential 2027 of . Most analysts recommend the Elanco Animal Health, Inc. stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Billion $ 4.72 5.23
6.22% 10.92%
EBITDA Margin 16.90% 19.90%
3.55% 17.73%
Net Margin -4.92% 11.07%
164.62% 324.98%

18 Analysts have issued a sales forecast Elanco Animal Health, Inc. 2026 . The average Elanco Animal Health, Inc. sales estimate is

$5.2b
unlock
. This is
4.18% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$5.4b 8.19%
unlock
, the lowest is
$5.0b 0.40%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $4.7b 6.22%
2026
$5.2b 10.92%
unlock
2027
$5.5b 5.37%
unlock
2028
$5.8b 4.92%
unlock
2029
$6.0b 2.97%
unlock
2030
$6.2b 3.73%
unlock
2031
$6.4b 2.96%
unlock
2032
$6.5b 2.83%
unlock
2033
$6.6b 1.18%
unlock

17 Analysts have issued an Elanco Animal Health, Inc. EBITDA forecast 2026. The average Elanco Animal Health, Inc. EBITDA estimate is

$1.0b
unlock
. This is
17.10% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$1.1b 22.61%
unlock
, the lowest is
$939m 5.61%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $797m 2.44%
2026
$1.0b 30.61%
unlock
2027
$1.1b 9.70%
unlock
2028
$1.3b 9.81%
unlock
2029
$1.5b 16.43%
unlock
2030
$1.6b 6.71%
unlock
2031
$1.4b 12.00%
unlock
2032
$1.4b 4.23%
unlock
2033
$1.5b 3.99%
unlock

EBITDA Margin

2025 16.90% 3.55%
2026
19.90% 17.73%
unlock
2027
20.72% 4.12%
unlock
2028
21.69% 4.68%
unlock
2029
24.52% 13.05%
unlock
2030
25.23% 2.90%
unlock

19 Elanco Animal Health, Inc. Analysts have issued a net profit forecast 2026. The average Elanco Animal Health, Inc. net profit estimate is

$579m
unlock
. This is
390.87% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$640m 421.57%
unlock
, the lowest is
$539m 370.61%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $-232m 168.64%
2026
$579m 349.50%
unlock
2027
$656m 13.28%
unlock
2028
$745m 13.58%
unlock
2029
$742m 0.34%
unlock
2030
$782m 5.38%
unlock
2031
$841m 7.49%
unlock
2032
$887m 5.45%
unlock
2033
$871m 1.72%
unlock

Net Margin

2025 -4.92% 164.62%
2026
11.07% 324.98%
unlock
2027
11.90% 7.50%
unlock
2028
12.88% 8.24%
unlock
2029
12.47% 3.18%
unlock
2030
12.66% 1.52%
unlock
2031
13.22% 4.42%
unlock
2032
13.56% 2.57%
unlock
2033
13.17% 2.88%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ -0.47 1.16
169.12% 346.81%
P/E 19.11
EV/Sales 2.76

19 Analysts have issued a Elanco Animal Health, Inc. forecast for earnings per share. The average Elanco Animal Health, Inc. EPS is

$1.16
unlock
. This is
397.44% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$1.28 428.21%
unlock
, the lowest is
$1.08 376.92%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $-0.47 169.12%
2026
$1.16 346.81%
unlock
2027
$1.31 12.93%
unlock
2028
$1.49 13.74%
unlock
2029
$1.49 0.00%
unlock
2030
$1.57 5.37%
unlock
2031
$1.68 7.01%
unlock
2032
$1.77 5.36%
unlock
2033
$1.74 1.69%
unlock

P/E ratio

Current -56.77 351.86%
2026
19.11 133.66%
unlock
2027
16.87 11.72%
unlock
2028
14.85 11.97%
unlock
2029
14.90 0.34%
unlock
2030
14.14 5.10%
unlock
2031
13.16 6.93%
unlock
2032
12.47 5.24%
unlock
2033
12.69 1.76%
unlock

Based on analysts' sales estimates for 2026, the Elanco Animal Health, Inc. stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.88 3.68%
2026
2.76 4.07%
unlock
2027
2.62 5.10%
unlock
2028
2.50 4.69%
unlock
2029
2.43 2.89%
unlock
2030
2.34 3.60%
unlock
2031
2.27 2.88%
unlock
2032
2.21 2.75%
unlock
2033
2.18 1.17%
unlock

P/S ratio

Current 2.20 1.42%
2026
2.12 4.02%
unlock
2027
2.01 5.10%
unlock
2028
1.91 4.69%
unlock
2029
1.86 2.89%
unlock
2030
1.79 3.59%
unlock
2031
1.74 2.88%
unlock
2032
1.69 2.75%
unlock
2033
1.67 1.16%
unlock

Current Elanco Animal Health, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
UBS
Locked
➜
Locked
Locked Aug 06 2026
Keybanc
Locked
➜
Locked
Locked Aug 06 2026
Morgan Stanley
Locked
➜
Locked
Locked Jul 22 2026
TD Cowen
Locked
➜
Locked
Locked Jun 18 2026
JP Morgan
Locked
➜
Locked
Locked May 07 2026
Citigroup
Locked
➜
Locked
Locked May 07 2026
Citigroup
Locked
➜
Locked
Locked Apr 15 2026
Analyst Rating Date
Locked
UBS:
Locked
➜
Locked
Aug 06 2026
Locked
Keybanc:
Locked
➜
Locked
Aug 06 2026
Locked
Morgan Stanley:
Locked
➜
Locked
Jul 22 2026
Locked
TD Cowen:
Locked
➜
Locked
Jun 18 2026
Locked
JP Morgan:
Locked
➜
Locked
May 07 2026
Locked
Citigroup:
Locked
➜
Locked
May 07 2026
Locked
Citigroup:
Locked
➜
Locked
Apr 15 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today